v3.26.1
Stock-Based Compensation (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Mar. 08, 2026
Jan. 14, 2026
Nov. 15, 2025
Nov. 14, 2025
Oct. 30, 2025
Jul. 30, 2025
Jul. 01, 2025
May 01, 2023
Mar. 28, 2022
Jul. 19, 2021
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2026
Jun. 29, 2026
Jun. 30, 2025
Apr. 01, 2026
Jul. 25, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock-based compensation                         $ 1,720,037   $ 884,531    
Weighted average remaining contractual term                         7 years        
Dividend yield                         $ 0        
Shares issued upon exercise                     $ 395,509            
Vesting period   4 years     4 years 12 months 4 years                    
July 19, 2021 [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock expenses                         50,092        
March 28, 2022 [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock expenses                         144,669        
May 1, 2023 [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock expenses                         $ 80,923        
Option Holders [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock options, exercised     15,000                   90,742        
Exercise price     $ 3.31                            
Shares withheld     3,439                   28,142        
Shares issued upon exercise     $ 11,561                   $ 62,600        
Exercise price of options exercised                         $ 8.00        
Stock option exercise price share                     1,000   1,000        
Option Holders [Member] | Exercise Price One [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock options, exercised                         81,951        
Exercise price of options exercised                         $ 3.31        
Option Holders [Member] | Exercise Price Two [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock options, exercised                         7,791        
Exercise price of options exercised                         $ 2.44        
Common Stock [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock-based compensation                         $ 1,720,037   $ 640,753    
Unrecognized stock-based compensation                     $ 6,000,774   $ 6,000,774        
Weighted average remaining contractual term                         4 years 4 months 2 days        
Stock options, exercised                     291 62,309          
Shares issued upon exercise                                
Stock option vested                         1,860,526        
Stock option exercise price                     $ 6.24   $ 6.24        
Stock option intrinsic value                     $ 3,986,993   $ 3,986,993        
Vesting period                         5 years 12 months      
Stock option expiration term                         7 years        
Common Stock [Member] | Share-Based Payment Arrangement, Option [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock option vested                         1,084,181        
Stock option exercise price                     $ 4.81   $ 4.81        
2025 Equity Incentive Plan [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Shares authorized for issuance                                 1,250,000
Restricted Stock Units (RSUs) [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Stock option vested 10,002                   39,259            
Vesting period             12 months                    
Restricted stock units granted   62,759         20,000 100,820 241,718 82,118     62,759        
Restricted stock value per share   $ 10.77         $ 9.48 $ 3.32 $ 2.44 $ 2.44     $ 10.77        
Expiration date               Apr. 01, 2026 Apr. 01, 2026 Apr. 01, 2026              
Weighted average remaining life, exercisable   7 years         7 years                    
Options exercised                         (49,261)        
Options vested                     417,385   417,385   424,656 15,689  
Restricted Stock Units (RSUs) [Member] | Lock Up Agreement [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Restricted stock units       424,656                          
Options exercised       7,870                          
Restricted Stock Units (RSUs) [Member] | July 19, 2021 [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Unrecognized stock-based compensation                     $ 150,276   $ 150,276        
Restricted Stock Units (RSUs) [Member] | March 28, 2022 [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Unrecognized stock-based compensation                     434,008   434,008        
Restricted Stock Units (RSUs) [Member] | May 1, 2023 [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Unrecognized stock-based compensation                     $ 242,770   $ 242,770        
2020 Plan [Member]                                  
Accumulated Other Comprehensive Income (Loss) [Line Items]                                  
Shares authorized for issuance               1,558,175     938,832   938,832